- Home
- BPOP vs KYMR Comparison
BPOP vs KYMR Comparison
Compare BPOP & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BPOP | KYMR |
|---|---|---|
| Founded | 1893 | 2015 |
| Country | United States | United States |
| Employees | 37 | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 9.0B |
| IPO Year | 1999 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BPOP | KYMR |
|---|---|---|
| Price | $159.09 | $110.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 24 |
| Target Price | ★ $195.20 | $139.35 |
| AVG Volume (30 Days) | 413.1K | ★ 743.5K |
| Earning Date | 10-22-2026 | 10-29-2026 |
| Dividend Yield | ★ 2.28% | N/A |
| EPS Growth | ★ 43.69 | N/A |
| EPS | ★ 8.13 | N/A |
| Revenue | ★ $756,100,000.00 | $39,211,000.00 |
| Revenue This Year | $8.13 | $167.19 |
| Revenue Next Year | $3.73 | N/A |
| P/E Ratio | $19.36 | ★ N/A |
| Revenue Growth | ★ 16.00 | N/A |
| 52 Week Low | $108.74 | $55.66 |
| 52 Week High | $179.24 | $130.05 |
Technical Indicators
Market Signals| Indicator | BPOP | KYMR |
|---|---|---|
| Relative Strength Index (RSI) | 48.94 | 50.14 |
| Support Level | $158.01 | $110.64 |
| Resistance Level | $160.06 | $119.89 |
| Average True Range (ATR) | 3.06 | 4.97 |
| MACD | 0.73 | 0.57 |
| Stochastic Oscillator | 63.53 | 67.77 |
Price Performance
Historical ComparisonAbout BPOP Popular Inc.
Popular Inc, based in Puerto Rico, is a financial holding company with four main subsidiaries: Banco Popular de Puerto Rico, a bank in Puerto Rico in terms of assets; Banco Popular North America, its banking operation in the continental United States; Evertec, a data processor; and Popular Financial Holdings, a diversified financial services company. The Corporation's reportable segments consist of Banco Popular de Puerto Rico and Popular U.S.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.